Fig. 2.
Genotyping results of HFs. Parents of children with SLOS clinical phenotypes Het-A through Het-F were gender and age matched with CTR fibroblasts. Mutations in Het-A through Het-F are classified as pathogenic or likely pathogenic DHCR7 variants. Genotyping of CTR HFs revealed two variants of unknown significance that were not previously described in SLOS clinical cases.